Related Experiment Videos
Postpartum depression recurrence versus discontinuation syndrome: observations from a randomized controlled trial
Keerthy R Sunder1, Katherine L Wisner, Barbara H Hanusa
1Department of Psychiatry, and Women's Behavioral HealthCARE, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
The Journal of Clinical Psychiatry
|September 16, 2004
Summary
A gradual 3-week sertraline taper did not cause discontinuation syndrome in women treated for postpartum depression. Extended preventive therapy to 26 weeks is recommended for future trials.
Area of Science:
- Psychiatry and Behavioral Sciences
- Clinical Pharmacology
Background:
- Postpartum depression recurrence is a significant concern.
- Differentiating antidepressant discontinuation syndrome from depressive relapse is crucial for effective management.
Purpose of the Study:
- To distinguish between antidepressant discontinuation syndrome and major depressive disorder recurrence.
- To evaluate sertraline (75 mg) discontinuation effects over a 3-week taper period.
Main Methods:
- A randomized clinical trial compared sertraline and placebo for preventing recurrent postpartum depression.
- Symptoms of discontinuation syndrome were assessed weekly during a 3-week taper phase using the Asberg Rating Scale for Side Effects (ASE).
- Depressive symptoms were monitored using the Hamilton Rating Scale for Depression.
Main Results:
- No significant differences in discontinuation symptoms were observed between sertraline and placebo groups during the taper.
- Both groups reported low levels of side effects.
- Depressive recurrence rates were low, with 0/3 placebo recipients and 2/8 sertraline recipients experiencing relapse within 6 weeks post-study.
Conclusions:
- A gradual 3-week taper of sertraline (75 mg) did not induce a discontinuation syndrome.
- Findings suggest extending preventive antidepressant therapy to 26 weeks in future randomized trials.
- This duration aligns with treatment guidelines for a single episode of depression.